Biltmore Capital Advisors’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-13,380	Closed	-$71K	–	69
2019 Q3	$71K	Sell	13,380 -3,000	-18%	-$15.9K	0.02%	72
2019 Q2	$63K	Buy	16,380 +980	+6%	+$3.77K	0.02%	71
2019 Q1	$79K	Buy	+15,400	New	+$79K	0.03%	62